“Chimeric ScFv Monoclonal Antibody Composed of Tocilizumab-Light Chain, Heavy Chain, and Bacterial Flagellin for the Treatment of Autoimmune Disorder: Insilco Design and Cytotoxicity Study”, Journal of Pharmaceutical Negative Results, pp. 644–659, Nov. 2022, Accessed: Jun. 30, 2026. [Online]. Available: https://pnrjournal.com/index.php/home/article/view/2794